Figure 3.
The suggested strategy for patients belonging to this group is single ASCT in patients chemosensitive to salvage therapy. For patients who achieve chemosensitivity only after ≥ third-line salvage chemotherapy, tandem ASCT could be considered. Consolidation RT could be considered after transplantation in selected indications. HTD: high-dose therapy; ASCT: autologous stem cell transplantation; RT: radiotherapy.